Sexual Differentiation and Disorders
37 ta ish
Reply to Tomasz Drewa and Piotr Chlosta's Letter to the Editor re: Frans Debruyne, Arkadij A. Gres, Dmitrii L. Arustamov. Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia. Eur Urol 2008;54:170–80
F. Debruyne, A A Gres, D. Arustamov
ABIСостояние показателей процессов апоптоза и ангиогенеза у больных с неактивными аденомами гипофиза
D.Sh. Kholova, Zamira Khalimova, Yu.М. Urmanova +2
MaqolaOchiq kirishGenetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesINTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)20160 iqtibosABIExamination of a pediatric urologist-andrologist. Why is it important to identify pathologies at an early stage
Садикова Дилфуза Ибрагимовна, Косимхожиев Мухаммаджон Иброхимжон, Курбанова Дилором Ибрагимовна +1
MaqolaOchiq kirishSexual Differentiation and DisordersZenodo (CERN European Organization for Nuclear Research)20210 iqtibosABITHE ROLE OF ESTROGENIC DEFICIENCY IN THE DEVELOPMENT AND PROGRESSION OF GENITAL PROLAPSE
Negmajanov Bahodur Boltaevich, Nasimova Nigina Rustamovna, Jalolova Iroda Abdujabborovna
MaqolaOchiq kirishUrological Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)20230 iqtibosABI